


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.35%
-1.61%
-2.59%
+1.82%
DTIL
Precision BioScience
$7.27

Login to see Precision BioScience (DTIL) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Outperform the market

Upgraded on attractively valued

Investors confidence is positive
DTIL Price Performance
$7.44 (-2.28%)
$3.79 (+91.82%)
$4.34 (+67.51%)
$5.04 (+44.25%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Earnings increase YoY
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Outperform the market
DTIL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DTIL Street Sentiment is extremely bullish and have positive views on the near-term outlook
DTIL has Extreme risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Apr 18, 2026
Downgrade
Neutral
Wells Fargo
Apr 16, 2026
Price Target Raised
Buy
Morgan Stanley
Apr 16, 2026
Reiterate
Buy
MoffettNathanson
Apr 15, 2026
Initiate
manufacturing
MoffettNathanson
Apr 13, 2026
Upgrade
a
Raymond James
What is DTIL current stock price?
What is DTIL current Stock IQ?
What is DTIL RSI signal right now?
What is DTIL analyst price target and upside potential?
What do analysts say about DTIL stock?
What is DTIL momentum trend right now?
What are DTIL stock strengths?
What is DTIL Risk Level?
Should I buy DTIL stock right now?
Is DTIL a Strong Buy right now?
What is DTIL market cap and volume?
What factors influence DTIL's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
DTIL
Precision BioScience
Current Price
$7.27
GILD
Gilead Sciences
129.58
-1.88%
MRNA
Moderna
49.04
-1.98%
CRSP
CRISPR Therapeutics
48.41
-4.04%
MAZE
Maze Therapeutics Inc.
25.56
-3.29%
BEAM
Beam Therapeutics In
27.93
-5.42%

DTIL Price Performance
$7.44 (-2.28%)
$3.79 (+91.82%)
$4.34 (+67.51%)
$5.04 (+44.25%)
DTIL Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Earnings increase YoY
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Outperform the market
DTIL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DTIL Street Sentiment is extremely bullish and have positive views on the near-term outlook
DTIL has Extreme risk level

Overall Wall Street Rating
DTIL Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market

Upgraded on attractively valued

Investors confidence is positive
DTIL Trading Signals
DTIL is now at $7.27, down -10.36% from $8.11. This rapid movement warrants attention.
DTIL is showing high volatility with an intraday swing of 11.17% (High: $8.06, Low: $7.25). This signals potential risk.
DTIL has a bearish MACD crossover with MACD (0.34) crossing below Signal (0.36). This signals negative momentum shift.
DTIL has positive earnings news: Beat Estimates. Cellectar Biosciences Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript. Cellectar Biosciences Inc. (NASDAQ: CLRB ) Q1 2026 Earnings Call Transcript...
DTIL beat earnings expectations. Cellectar Biosciences Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript. Cellectar Biosciences Inc. (NASDAQ: CLRB ) Q1 2026 Earnings Call Transcript...
DTIL received an analyst price target change. Leslie’.s Inc. (NASDAQ:LESL) Q2 2026 Earnings Call Transcript. Leslies Inc. (NASDAQ: LESL ) Q2 2026 Earnings Call Transcript May 13 2026 Leslies ...
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
DTIL Stock trends
DTIL Stock performance
DTIL Stock analysis
DTIL investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.